Sequenom Licenses Rights to Macular Degeneration Genetic Test

Sequenom expects its CLIA lab to launch the test in early 2011.

Qiagen Licenses Biomarker IP from Johns Hopkins

The company plans to use the PI3K gene to develop companion diagnostics for cancer drugs.

Qiagen's Revenues Rise 22 Percent in Q4, Eclipse $1B Mark for FY 2009

Qiagen's revenues were driven by its molecular diagnostics sales, which now account for nearly 50 percent of the firm's total sales.

Clinical Data Revenues up 11 Percent in Q3

Sales of its Familion genetic tests were a primary driver of revenue growth for the quarter.

Compugen Cuts Q4 Loss on Decreased Spending

The firm reported insignificant revenues but cut its loss on decreased spending. It hopes to be cash flow breakeven by the end of 2011.

CDC to Fund Genomics Knowledge Center

The $1.5 million grant will start a center to review and generate evidence on genomics applications.

DNAVision Adds Illumina HiSeq to Service Offerings

The HiSeq 2000 joins DNAVision's other next-gen sequencing platforms that are used in its genomics services offerings.

EU, India to Partner on Joint Research Efforts

The New Indigo project will involve Indian and EU state partners on bioinformatics, biomarker, and diagnostics studies.

Institute for Systems Biology Mulls Expansion, Focusing on P4 Efforts

ISB Co-founder and President Leroy Hood told GenomeWeb Daily News in a wide-ranging interview that the institute is considering a consolidation and expansion of its facilities. He also provided updates on a variety of ongoing collaborations focused on personalized medicine.

Varian's Q1 Revenues Slip in Advance of Agilent Merger Completion

Varian's Q1 revenues dipped 3 percent due to lower sales volume and lower average selling prices of certain analytical instruments products, the firm said.

Denator Inks Swiss Distribution Pact

Bucher Biotec will market and service Denator's protein and peptide sample stabilization technology in Switzerland.

HHS Advisory Group Proposes Gene Patent Limits, Riles Industry

The SACGHS report advises changes in the law to release diagnostic nucleic acid-based tests and genetics research from infringement liability.

Abbott Files US Suit Against Qiagen Over HPV IP Dispute

Abbott wants the court to compel Qiagen to participate in arbitration over a licensing deal covering HPV IP.